Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Student leaders' hard work rewarded
2013-05-01

Four student leaders on our Bloemfontein and Qwaqwa Campuses each received a scholarship of R15 000. Handré Hay, Estine Cronje, Tsepang Lenka and Jean Vermaas were rewarded for the positive impact they had on the student community in the past three years or more. Student Affairs' scholarship programme acknowledges the contribution of student leaders in the upliftment of the student community.

Read what the four have to say about leadership:

Handré Hay:

Handré Hay, a third-year BSc Physiotherapy student who holds several leadership positions on our Bloemfontein Campus, served for two consecutive years on the committee of Armentum residence. He was also a member of the executive council in the Students' Representative Council (SRC) and served in two SRC portfolios. "Leadership is about being able to serve. When people see that you are willing to put other people's interests above your own and that you are willing to serve unselfishly, despite a position of authority, you will get far," said Handré.

Estine Cronje:

Estine Cronje is the current prime of Marjolein residence. This was the second time the fifth-year Psychology student were re-elected to this position."Leadership is very important to me. One needs leaders in everything you do. I believe a leader should never think herself better than the rest and should work as hard as her team. She should command respect, be disciplined, an example to others, accessible and open to the opinions of other people.

Tsepang Lenka:

Tsepang Lenka is the SRC President of our Qwaqwa Campus. Tsepang, who was twice elected as prime of his residence, has already obtained his BA degree in Public and Business Management. He is currently working on his Postgraduate Certificate in Education (PGCE). "To me leadership means to serve. As a leader you don't lie to people when things are taking the wrong direction, you stand firm and tell the truth; in that way, people don't lose trust in you. The scholarship inspires me to work even harder," Tsepang said.

Jean Vermaas:

Jean Vermaas is a former SRC member who is currently studying for his LLB degree. Some of Jean's achievements include leadership positions of the Juridical Society and the Broad Students' Transformation Forum. In 2012 he was a founder member of the Student Elders' Council."Leadership is of extreme importance to me. It formed me into the person I am now. Leadership isn't always easy, but in the challenges you face you grow as a leader and as an individual."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept